These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2146899)

  • 1. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome cases.
    Takashima S; Kuruta H; Mito T; Nishizawa M; Kunishita T; Tabira T
    Brain Dev; 1990; 12(4):367-71. PubMed ID: 2146899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of beta-amyloid protein deposited lesions in Down's syndrome brains.
    Ikeda S; Tokuda T; Yanagisawa N; Kametani F; Ohshima T; Allsop D
    Tohoku J Exp Med; 1994 Nov; 174(3):189-98. PubMed ID: 7761984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome.
    Arai Y; Uchida Y; Takashima S
    Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains.
    Arai Y; Suzuki A; Mizuguchi M; Takashima S
    Brain Dev; 1997 Jun; 19(4):290-4. PubMed ID: 9187481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory form of beta-amyloid precursor protein is much abundantly contained in the cerebral white matter in human brain.
    Tokuda T; Tanaka K; Kametani F; Ikeda S; Yanagisawa N
    Neurosci Lett; 1994 Jul; 175(1-2):33-6. PubMed ID: 7970206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia.
    Motonaga K; Itoh M; Hirayama A; Hirano S; Becker LE; Goto Y; Takashima S
    Brain Res; 2001 Jun; 905(1-2):250-3. PubMed ID: 11423103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subpial beta/A4 amyloid deposition occurs between astroglial processes in Alzheimer-type dementia.
    Yamaguchi H; Nakazato Y; Yamazaki T; Shoji M; Kawarabayashi T; Hirai S
    Neurosci Lett; 1991 Feb; 123(2):217-20. PubMed ID: 2027535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome.
    Crino PB; Martin JA; Hill WD; Greenberg B; Lee VM; Trojanowski JQ
    Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):655-61. PubMed ID: 7639477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
    Busciglio J; Pelsman A; Wong C; Pigino G; Yuan M; Mori H; Yankner BA
    Neuron; 2002 Feb; 33(5):677-88. PubMed ID: 11879646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.
    Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL
    Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains.
    Arai Y; Mizuguchi M; Ikeda K; Takashima S
    Brain Res Dev Brain Res; 1995 Jul; 87(2):228-32. PubMed ID: 7586507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subpial beta/A4 peptide deposits are closely associated with amyloid angiopathy in the elderly.
    Itoh Y; Yamada M; Hayakawa M; Otomo E; Miyatake T
    Neurosci Lett; 1993 Jun; 155(2):144-7. PubMed ID: 8377943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
    Armstrong RA
    Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
    Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
    Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
    Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.